Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Beloveza – page 4

195 clinical trials in Beloveza, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Beloveza at a glance
195
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

195 trials in Beloveza

Open in trial search

A study to evaluate the efficacy and safety of orforglipron in patients with peripheral artery disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Orforglipron hemicalcium
  • Sponsor:Eli Lilly & Co.

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Osavampator
  • Sponsor:Neurocrine Biosciences Inc.

Study of GHZ339 for treatment of moderate to severe atopic dermatitis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:GHZ339
  • Sponsor:Novartis Pharma AG

Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Osavampator
  • Sponsor:Neurocrine Biosciences Inc.

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

COVID-19

Recruiting

Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ibuzatrelvir
  • Sponsor:Pfizer Inc.

Psychotic disorder+2

Recruiting

Study on ITI-1284 for Treating Psychosis in Alzheimer's Patients

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Astellas Pharma Global Development Inc.

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:MK-1084
  • Sponsor:Merck Sharp & Dohme LLC

Psoriasis

Recruiting

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Etanercept
  • Sponsor:Sun Pharmaceutical Industries Limited

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Beloveza

What the registry says about research in the country

01 Cardiovascular Research

Clinical research focusing on Atrial Fibrillation management and stroke prevention. The studies aim to evaluate new therapeutic approaches for preventing cardioembolic events in patients with cardiac arrhythmias.

  • Stroke Prevention
  • Cardiac Arrhythmia Management
  • Cardioembolic Event Prevention

These investigations represent significant advancement in cardiovascular medicine, exploring innovative treatments for patients with heart rhythm disorders.

02 Thrombosis Prevention

Groundbreaking research evaluating new approaches in anticoagulation therapy. The trials focus on comparing novel treatments with established medications for preventing blood clots and related complications.

  • Blood Clot Prevention
  • Systemic Embolism Management
  • Comparative Treatment Studies

These studies aim to expand treatment options for patients requiring long-term anticoagulation therapy.

03 Clinical Outcomes Research

Investigation of therapeutic efficacy in preventing serious cardiovascular complications. The research evaluates non-CNS systemic embolism and stroke prevention strategies.

  • Treatment Effectiveness
  • Patient Safety Evaluation
  • Comparative Clinical Outcomes

This research contributes to advancing evidence-based treatment protocols in cardiovascular medicine.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.